Influence of prescription charges on repeat prescribing in primary care

被引:2
作者
Bradley, F. [1 ]
Elvey, R. [1 ]
Ashcroft, D. M. [1 ]
Noyce, P. [1 ]
机构
[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Ctr Innovat Practice, Manchester M13 9PL, Lancs, England
关键词
charges; general practice; prescription; repeat prescribing;
D O I
10.1111/j.1365-2710.2007.00821.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Repeat dispensing by community pharmacists has now been rolled out nationally within England in order to improve patient convenience and reduce doctors' workload. Little is known about how the charge status of the patient may impact on the uptake and prescribing practices of this service. Objective: To examine whether the charge status of the patient influences the length of the repeat prescribing cycle. Method: Thirty-six community pharmacies collected data on repeatable prescriptions dispensed over a 4-month period. A purposive sample of 13 general practices actively involved as pathfinder sites were selected for interview, to explore views on repeat prescriptions and influence of prescription charges. Results: Completed audit forms were collected on 4029 repeatable prescriptions. Differences in the length of the prescribing interval between charge payers and exempt patients were found to be statistically significant (Mann-Whitney U-test, P < 0.001), indicating that prescribers were issuing prescriptions for longer interval periods for charge payers. Thirteen general practitioners (GPs) and three practice managers were interviewed across 13 practices. Some GPs varied their prescribing to minimize the cost to patients. Others were motivated to reduce waste an promoted 28-day prescribing for all patients. Conclusion: The study has shown that charge paying patients are more likely to have longer prescribing intervals and that cost to the patient is a consideration for GPs when making these decisions. Future work should explore the influence of other factors such as age, socio-economic status and patient morbidity on prescribing in primary care.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 11 条
[1]   Affordability of medicines and patients' cost-reducing behaviour: Empirical evidence based on SUR estimates from italy and the UK [J].
Atella V. ;
Schafheutle E. ;
Noyce P. ;
Hassell K. .
Applied Health Economics and Health Policy, 2005, 4 (1) :23-35
[2]  
ELVEY R, 2006, PRESCRIBER, V17, P12
[3]  
Harris CM, 1996, BRIT J GEN PRACT, V46, P649
[4]  
*HOUSE COMM HLTH C, 2004, NHS CHARG 3 REP SESS
[5]  
*INF CTR HLTH SOC, 2006, PRESCR DISP COMM STA
[6]  
McGavock H, 1999, BRIT J GEN PRACT, V49, P343
[7]  
MCKINNON M, 2001, PRIM HEALTH CARE RES, V2, P235, DOI DOI 10.1191/146342301682157719
[8]  
*PHARM SERV NEG CO, 2004, NEW CONTR COMM PHARM
[9]   Access to medicines: cost as an influence on the views and behaviour of patients [J].
Schafheutle, EI ;
Hassell, K ;
Noyce, PR ;
Weiss, MC .
HEALTH & SOCIAL CARE IN THE COMMUNITY, 2002, 10 (03) :187-195
[10]  
WEISS MC, 2001, J GENERAL PRACTICE, V7, P23